Cliff Asness's XERS Position Overview
Cliff Asness (via Aqr Capital Management LLC) currently holds 1.54 M shares of Xeris Biopharma Holdings, Inc. (XERS) worth $12.2 M, representing 0.00% of the portfolio. First purchased in 2022-Q3, this medium-term investment has been held for 16 quarters.
Based on 13F filings, Cliff Asness has maintained a strategic position in XERS, demonstrating sustained confidence in this investment. Largest addition occurred in Q1 2024, adding 867,784 shares. Largest reduction occurred in Q4 2024, reducing 233,176 shares.
Analysis based on 13F filings available since 2013 Q2
Cliff Asness's Xeris Biopharma Holdings (XERS) Holding Value Over Time
Track share changes against reported price movement
Quarterly Xeris Biopharma Holdings (XERS) Trades by Cliff Asness
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | +146,609 | Add 10.51% | 1.54 M | $7.92 |
| Q1 2026 | +436,797 | Add 45.61% | 1.39 M | $5.80 |
| Q4 2025 | -26,021 | Reduce 2.65% | 957,579 | $7.85 |
| Q3 2025 | -65,393 | Reduce 6.23% | 983,600 | $8.14 |
| Q2 2025 | +102,227 | Add 10.80% | 1.05 M | $4.67 |
| Q1 2025 | +111,826 | Add 13.39% | 946,766 | $5.49 |
| Q4 2024 | -233,176 | Reduce 21.83% | 834,940 | $3.39 |
| Q3 2024 | -124,964 | Reduce 10.47% | 1.07 M | $2.85 |
| Q2 2024 | +52,074 | Add 4.56% | 1.19 M | $2.25 |
| Q1 2024 | +867,784 | Add 317.61% | 1.14 M | $2.21 |
| Q4 2023 | +230,942 | Add 546.22% | 273,222 | $2.35 |
| Q3 2023 | +28,612 | Add 209.34% | 42,280 | $1.86 |
| Q2 2023 | -17,898 | Reduce 56.70% | 13,668 | $2.62 |
| Q1 2023 | -18,688 | Reduce 37.19% | 31,566 | $1.63 |
| Q4 2022 | +29,712 | Add 144.64% | 50,254 | $1.33 |
| Q3 2022 | +20,542 | New Buy | 20,542 | $1.56 |
Cliff Asness's Xeris Biopharma Holdings Investment FAQs
Cliff Asness first purchased Xeris Biopharma Holdings, Inc. (XERS) in Q3 2022, acquiring 20,542 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Cliff Asness has held Xeris Biopharma Holdings, Inc. (XERS) for 16 quarters since Q3 2022.
Cliff Asness's largest addition to Xeris Biopharma Holdings, Inc. (XERS) was in Q1 2024, adding 1,141,006 shares worth $2.52 M.
According to the latest 13F filing for Q2 2026, Cliff Asness's firm, Aqr Capital Management LLC, owns 1,540,985 shares of Xeris Biopharma Holdings, Inc. (XERS), valued at approximately $12.2 M.
As of the Q2 2026 filing, Xeris Biopharma Holdings, Inc. (XERS) represents approximately 0.00% of Cliff Asness's publicly disclosed stock portfolio, making it one of their key holdings.
Cliff Asness's peak holding in Xeris Biopharma Holdings, Inc. (XERS) was 1,540,985 shares, as reported at the end of Q2 2026.